HR Execs on the Move

Immunic

www.imux.com

 
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products: its lead development program, IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect, is currently being developed as a treatment option for multiple sclerosis, ulcerative colitis, Crohn`s disease, and primary sclerosing cholangitis. IMU-935, a selective inverse agonist of the transcription factor RORγt, is targeted for development in psoriasis and Guillain-Barré syndrome. ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imux.com
  • 1200 Avenue of the Americas Suite 200
    New York, NY USA 10036
  • Phone: 332.255.9811

Executives

Name Title Contact Details

Similar Companies

Headway Emotional Health Services

Our psychiatrists, case workers, and medical and administrative staff are dedicated to helping people in emotional distress transform their lives through treatment, intervention and education. Headways services include outpatient therapy, DBT, psychia...

Cynapsus Therapeutics

Cynapsus Therapeutics Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Barlean`s

The family owned and operated company produces the finest and freshest organic flaxseed oil, Fresh Catch fish oil, green food supplements and other premium essential fatty acid products.

Mayfield Brain & Spine

The Mayfield Surgical Innovation Center is a state-of-the-art training facility for spine and cranial surgery technology and minimally invasive procedures.

HI-Bio

HI Bio is a clinical stage biotechnology company focused on the development of targeted therapies for patients with immune mediated diseases (IMDs).